With better screening for type 1 diabetes and a new treatment called TZield, the outlook is improving for people with the ...

Disease-modifying therapies for type 1 diabetes are beginning to move care beyond insulin replacement by targeting immune ...

According to the CDC, just over 1 in 10 US adults live with diabetes. What’s even more important is that more than 1 in 3 US ...

More than 1 in 10 Americans have diabetes—that’s a lot of people. But diabetes isn’t just one universal condition. There are many different types. All types involve problems with blood sugar ...

Diabetes affects 37 million people in the U.S. The Centers for Disease Control and Prevention estimates another 96 million people – or 1 in 3 adults – have prediabetes, a condition where blood sugar ...

Insulin, a hormone medication used to regulate blood sugar, has long been one of the most important therapies for managing type 2 diabetes. But with the rise of semaglutide (Ozempic) and other ...

How Does Tzield Work in Type 1 Diabetes? Type 1 diabetes is an autoimmune disease in which your immune system mistakenly attacks and damages the beta cells in your pancreas. The beta cells produce ...

When diabetes causes CKD, it’s sometimes called diabetic kidney disease. Elevated blood sugar levels that result from diabetes can damage the tiny blood vessels inside your kidneys. As a result, your ...

For decades, most people were told the same thing after a Type 2 diabetes diagnosis.

Stem cells offer an extraordinary toolkit for science and medicine. Researchers are getting better at turning these ...